Zymeworks' Series A - III Round

Zymeworks raised a round of funding on October 23, 2014.

Zymeworks (NYSE: ZYME) (TSX: ZYME) is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of multifunctional biotherapeutics.…

Articles about Zymeworks' Series A - III Round: